BioPharma Credit BPCR.L · GBp

Its shares trade on LSE under the ticker BPCR.L. It has been listed since 27 March 2017. In the fiscal year to 31 December 2025, it reported net income of $129.9m. At that date it held total assets of $1.17bn and shareholders' equity of $1.15bn.

BioPharma Credit PLC is a GB-based company operating in Capital Markets industry. The company is headquartered in Exeter, Devon. The company went IPO on 2017-03-27. BioPharma Credit PLC is a United Kingdom-based, closed-ended investment trust. The principal activity of the Company is to invest in interest-bearing-debt assets with a contractual right to future cash flows derived from royalties or sales of approved life sciences products. The firm's investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The firm seeks to achieve its investment objectives through direct or indirect exposure to debt assets. Its diversified portfolio is primarily secured by cash flows derived from sales of approved life sciences products. The firm holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership. Its portfolio of investments includes senior secured corporate loans, senior secured royalty loans, unsecured convertible bonds, and equity. The firm's investment manager is Pharmakon Advisors L.P.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Harry HymanNon-Executive Independent Chairman of the Board$124,234
• Mr. Colin BondNon-Executive Independent Director$112,549
• Mr. Duncan BudgeSenior Non-Executive Independent Director$88,501
• Mrs. Stephanie LeouzonNon-Executive Independent Director$90,138
• Ms. Sapna ShahNon-Executive Independent Director$87,510
• Mr. Rolf SoderstromNon-Executive Independent Director$88,854

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.